MUMBAI, Sept 18 (Reuters) - India’s top drug makers are in the race to acquire U.S.-based generic drug maker, Par Pharmaceutical Co Inc (PRX.N: Quote, Profile, Research), two Indian newspapers reported on Tuesday.
MUMBAI, Sept 18 (Reuters) - India’s top drug makers are in the race to acquire U.S.-based generic drug maker, Par Pharmaceutical Co Inc (PRX.N: Quote, Profile, Research), two Indian newspapers reported on Tuesday.
